Market Tracker

02/23 5:15pm ET

Inspyr Therapeutics Inc (OTCQB:NSPX)

0.0325
Delayed Data
As of Feb 23
 +0.0025 / +8.33%
Today’s Change
0.02
Today|||52-Week Range
0.57
+30.00%
Year-to-Date
No recent news for Inspyr Therapeutics Inc.

Today’s Trading

Previous close0.03
Today’s open0.03
Day’s range0.03 - 0.03
Volume28,551
Average volume (3 months)40,774
Market cap$287.4K
Data as of 12:23pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 15, 2017
EPS forecast (this quarter)-$25.50
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, CAO &
Executive Director
Christopher P. Lowe
Vice President-
Clinical Operations
Michael Elliott
Corporate headquarters
Westlake Village, California

Forecasts